Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

@article{GmezReino2006SwitchingTA,
  title={Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period},
  author={Juan J G{\'o}mez-Reino and Loreto Carmona},
  journal={Arthritis Research & Therapy},
  year={2006},
  volume={8},
  pages={R29 - R29}
}
The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of patients with different forms of chronic arthritis who are treated with biologics. Using this registry, we have… CONTINUE READING